Eydelman Mikhail sold PCVX
January 2, 2024 · Form 4 insider transaction
Eydelman Mikhail sold 928 shares of Vaxcyte, Inc. at $64.31 per share, a transaction worth $59.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
928
Price
$64.31
Total value
$59.7K
InsiderEydelman Mikhail
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after20,710
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.; The price reported is a weighted-average price. The shares were sold at prices ranging from $64.13 to $65.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.